Skip to main content
. 2015 Nov 7;21(41):11877–11886. doi: 10.3748/wjg.v21.i41.11877

Table 4.

Other nomograms relevant to colorectal cancer

Ref. Year Targeted patients Treatment Predicted outcome Number of patients C-index Validation Calibration Variables Comments
Jwa et al[37] 2014 Non-metastatic rectal cancer CRT + surgery ypN status 891 0.77-0.81 Present Present ypT, cN, histology, lymphovascular invasion, perineural invasion, age
van Stiphout et al[38] 2011 Rectal cancer CRT + surgery Pathologic complete response 953 Not assessed Present Present tumor length, RI, SUV Pre- and post-CRT PET-CTs were used to predict response
van Stiphout et al[39] 2014 Rectal cancer CRT + surgery Pathologic complete response 190 0.70-0.78 Present Absent Maximal diameter at day 15, RI, cN Pre- and intra-CRT PET-CTs were used to predict response
Omata et al[40] 2011 Asymptomatic individuals Colorectal neoplasms 1085 Not assessed Absent Absent Quantitative fecal immunochemical test, gender, age, BMI
Kawai et al[41] 2014 Colorectal cancer Surgery Postoperative development of metachronous colorectal neoplasms 309 0.71 Present Present Gender, age, No. of synchronous adenomas and colorectal cancers
Wells et al[42] 2014 Age > 45 Colorectal cancer development 180630 0.68 Absent Present Age, ethnicity, smoking, alcoholic drinks, BMI, education, aspirin, estrogen, family history of CRC, NSAIDs, multivitamins, red meat intake, diabetes, physical activity

CRT: Chemoradiotherapy; PET-CT: Positron emission tomography-computed tomography; RI: Response index; SUV: Standardized uptake value; CRC: Colorectal cancer; BMI: Body mass index; C-index: Concordance index; NSAID: Non-steroidal anti-inflammatory drug.